Assessment of the change in cetuximab-induced antibody-dependent cellular cytotoxicity activity of natural killer cells by steroid
Author:
Affiliation:
1. Department of Pathology; Asahikawa Medical University; Asahikawa Japan
2. Department of Otolaryngology, Head and Neck Surgery; Asahikawa Medical University; Asahikawa Japan
Funder
JSPS KAKENHI
Publisher
Wiley
Subject
Otorhinolaryngology
Reference23 articles.
1. Improving the efficacy of antibody-based cancer therapies;Carter;Nat Rev Cancer,2001
2. IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma;Maloney;Blood,1997
3. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected];Fukuoka;J Clin Oncol,2003
4. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin;Zuo;J Cell Biochem,2011
5. Phase I study of anti-epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer;Robert;J Clin Oncol,2001
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exploring Immunological Effects and Novel Immune Adjuvants in Immunotherapy for Salivary Gland Cancers;Cancers;2024-03-19
2. Steroid Premedication and Monoclonal Antibody Therapy: Should We Reconsider?;Current Treatment Options in Oncology;2024-01-03
3. 次世代リーダーの育成―頭頸部癌に対する免疫療法の最前線―;Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho(Tokyo);2023-02-20
4. 功成り名遂げて身退くは, 天の道なり;Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho(Tokyo);2022-10-20
5. WX-0593 combined with an epithelial growth factor receptor (EGFR) monoclonal antibody in the treatment of xenograft tumors carrying triple EGFR mutations;Annals of Translational Medicine;2022-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3